Vimarsana
Biggest News Aggregation in the World

Page 36 - Cell Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Division Today - Breaking & Trending Today

Researchers discover a key role played by ch-TOG protein in the initiation of microtubule assembly - Vimarsana News

Researchers discover a key role played by ch-TOG protein in the initiation of microtubule assembly

Microtubules are cellular fibres that are part of the skeleton of the cell, termed cytoskeleton. They ensure that cells maintain their shape, carry out their functions, and divide.

Using artificial human skin to block invasive growth in a skin cancer model - Vimarsana News

Using artificial human skin to block invasive growth in a skin cancer model

By using artificial human skin, a research group from the University of Copenhagen have managed to block invasive growth in a skin cancer model.

Study uncovers protein that acts as a brake for DNA replication - Vimarsana News

Study uncovers protein that acts as a brake for DNA replication

A protein that prepares DNA for replication also prevents the replication process from running out of control, according to a new study by Weill Cornell Medicine researchers.

Metastatic Melanoma: key protein identified that aids the spread of skin cancer - Vimarsana News

Metastatic Melanoma: key protein identified that aids the spread of skin cancer

In this interview, News-Medical spoke to Dr. Jeremy Carlton and Professor Victoria Sanz-Moreno about their latest research into the spread of skin cancer.

Mutations may underlie how the most aggressive lymphomas arise and resist therapies - Vimarsana News

Mutations may underlie how the most aggressive lymphomas arise and resist therapies

The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells, according to a multi-institutional preclinical study led by Weill Cornell Medicine investigators.